Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

6
Number of overlapping holdings
9.1%
% of HART's 75 holdings also in PJP
20.0%
% of PJP's 30 holdings also in HART
Overlap by Weight
Sector Drift (HART minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in HART |
Weight in PJP |
Overlap | |
---|---|---|---|---|
ABBOTT LABORATORIES | 5.7% | 5.3% | 5.3% | |
JOHNSON & JOHNSON | 5.3% | 5.1% | 5.1% | |
ELI LILLY & CO | 5.4% | 4.9% | 4.9% | |
PFIZER INC | 5.0% | 4.9% | 4.9% | |
BRISTOL-MYERS SQUIBB CO | 5.1% | 2.6% | 2.6% |
Position Highlights (Non-Overlapping Exposures)
HART Overweight Relative to PJP
ASTRAZENECA PLC | 5.6% | |
BOSTON SCIENTIFIC CORP | 5.4% | |
MEDTRONIC PLC | 5.4% | |
NOVARTIS AG | 5.3% | |
ALPHABET INC. CLASS A | 5.0% | |
APPLE INC | 4.9% | |
SANOFI-AVENTIS | 4.0% | |
NOVO NORDISK A/S-B | 4.0% | |
ELEVANCE HEALTH INC | 2.8% | |
NIKE INC -CL B | 2.7% |
HART Underweight Relative to PJP
ABBVIE INC | -5.2% | |
GILEAD SCIENCES INC | -5.0% | |
MERCK & CO. INC. | -4.9% | |
AMGEN INC | -4.8% | |
BIOSANTE PHARMACEUTICALS INC | -3.9% | |
CORCEPT THERAPEUTICS INC | -3.5% | |
TARSUS PHARMACEUTICALS, INC. | -3.4% | |
PACIRA PHARMACEUTICALS INC | -3.1% | |
INNOVIVA, INC. | -3.1% | |
LIQUIDIA TECHNOLOGIES, INC. | -3.0% |